Earnings Outlook For Augmedix
Portfolio Pulse from Benzinga Insights
Augmedix (NASDAQ:AUGX) is scheduled to release its quarterly earnings report on March 18, 2024, with an expected EPS of $-0.10. Analysts and investors are looking for an earnings beat and positive guidance for the next quarter. Historically, Augmedix has shown the ability to surpass EPS estimates, leading to significant stock price movements. The company's shares have increased by 112.42% over the last 52 weeks, indicating a positive outlook from long-term shareholders.
March 15, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Augmedix is anticipated to report a quarterly EPS of $-0.10 on March 18, 2024. The company's history of surpassing earnings estimates and the positive trend in its stock price over the past year suggest a potentially bullish outlook for its stock in the short term.
Augmedix's expected EPS of $-0.10 and its history of beating earnings estimates could lead to positive investor sentiment. Given the stock's 112.42% increase over the past year, a continuation of this trend with another earnings beat and positive guidance could further boost the stock price in the short term.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100